Evaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items.
about
New MRI Biomarkers Advance the Characterization of Parkinson Disease.Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.Rivastigmine in Alzheimer's disease and Parkinson's disease dementia: an ADAS-cog factor analysis.The anticholinesterase phenserine and its enantiomer posiphen as 5'untranslated-region-directed translation blockers of the Parkinson's alpha synuclein expressionParkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias.Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study.Clinical trials of dementia with Lewy bodies and Parkinson's disease dementia.Efficacy of higher-dose 13.3 mg/24 h (15 cm2) rivastigmine patch on the Alzheimer's Disease Assessment Scale-cognitive subscale: domain and individual item analysis.
P2860
Q30835312-DAD5E854-9340-4415-A45D-0D6EA9E9C408Q33596451-56A28DE7-F5E0-4DC1-ACC8-1C50C1CC2A8EQ34051079-1E70462D-07EE-4A04-AE13-4769047F8CE7Q36012226-EEE0A59F-D352-41A6-A7BC-14C65E77C43CQ36351543-8989D746-4879-4B87-8913-FB30363B0A3BQ47923287-45BFDC59-6364-45D3-A084-5C2C5631F4F3Q48084523-3E6C45F8-24E4-4032-8634-48C3E14EAB28Q48642615-6D8D2871-0036-48A9-9F42-C95E5A87B7B3Q50860260-78339D81-77CD-4E2A-A990-D557C52439EA
P2860
Evaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Evaluating rivastigmine in mil ...... dementia using ADAS-cog items.
@en
Evaluating rivastigmine in mil ...... dementia using ADAS-cog items.
@nl
type
label
Evaluating rivastigmine in mil ...... dementia using ADAS-cog items.
@en
Evaluating rivastigmine in mil ...... dementia using ADAS-cog items.
@nl
prefLabel
Evaluating rivastigmine in mil ...... dementia using ADAS-cog items.
@en
Evaluating rivastigmine in mil ...... dementia using ADAS-cog items.
@nl
P2093
P2860
P356
P1476
Evaluating rivastigmine in mil ...... dementia using ADAS-cog items
@en
P2093
Frederick A Schmitt
Jason T Olin
Sibel Tekin
Xiangyi Meng
P2860
P304
P356
10.1177/1533317510367486
P407
P577
2010-04-14T00:00:00Z